Physician profile

Dean Patrick Springstead

Family · Boulder, CO

NPI 1396189650

$2,145.66

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,054.05
Food and Beverage$1,022.01

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $1,722.48 2023 Linq II
Boston Scientific Corporation $339.19 2023-2024 Watchman Access System
Abbott Laboratories $29.96 2021-2022
Biotronik INC. $20.25 2022
E.R. Squibb & Sons, L.L.C. $19.39 2022
Atricure, INC. $14.39 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dean Patrick Springstead

$2,145.66

in general payments reported 2019-2025

Years
2021-2024
Top company
Medtronic, INC.

https://glasscript.com/doctor/10707625/dean-patrick-springstead

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.